Cinctive Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cinctive Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-53,080	Closed	-$3.94M	–	635
2022 Q2	$3.94M	Buy	+53,080	New	+$3.98M	0.17%	204

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Cinctive Capital Management's XBI Position: Q3 2022 in Review

Cinctive Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 53,080 shares — an estimated $3.94M sold.

Cinctive Capital Management first reported a position in XBI in Q2 2022 and held it in 1 quarter. The position peaked at $3.94M in Q2 2022. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Cinctive Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
Cinctive Capital Management sold 53,080 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $3.94M.
Cinctive Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 1 quarter.
Cinctive Capital Management's State Street SPDR S&P Biotech ETF position peaked at $3.94M in Q2 2022.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Cinctive Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.